The largest database of trusted experimental protocols

Dionex ultimate 3000 biors

Manufactured by Thermo Fisher Scientific
Sourced in United States

The Dionex™ UltiMate™ 3000 BioRS is a high-performance liquid chromatography (HPLC) system designed for biopharmaceutical analysis. It features a modular design, precise flow control, and advanced detection capabilities to support a wide range of analytical applications.

Automatically generated - may contain errors

5 protocols using dionex ultimate 3000 biors

1

Paracetamol Quantification in Solid Oral Formulations

Check if the same lab product or an alternative is used in the 5 most similar protocols
For each printing run, three individual SOFs were dissolved in 100 mL of distilled water. Samples of the solutions were then diluted, and the drug concentration was determined through ultra-high performance liquid chromatography (UHPLC) using a UHPLC-DAD system. It consisted of a Thermo Scientific™ Dionex™ UltiMate™ 3000 BioRS equipped with a WPS-3000TBRS autosampler, and a TCC-3000RS column compartment set at 35 °C (Thermofisher Scientific, Waltham, MA, USA). The system was operated using Chromeleon 7 software. An Accucore C18 column (2.6 µm, 100 × 2.1 mm) combined with a security guard ultra-cartridge (Phenomenex Inc., Torrance, CA, USA) was used. An isocratic binary solvent system was utilized, consisting of water/formic acid (0.1%, v/v) as solvent A, and acetonitrile/formic acid (0.1%, v/v) as solvent B (90%A, 10%B). The flow rate of the mobile phase was 1.5 mL/minute, and the injection volume was 50 μL. Quantitative analysis of paracetamol in the SOFs was carried out using an external standard method. The calibration curve was constructed using 5 different standard levels in the concentration range 1–20 mg/L. The peak of paracetamol was monitored at 244 nm.
+ Open protocol
+ Expand
2

Paracetamol Quantification in SODF

Check if the same lab product or an alternative is used in the 5 most similar protocols
For each formulation, three individual SODFs were dissolved in 100 mL of distilled water. Samples of the solutions were then diluted and the drug concentration was determined by ultra-high performance liquid chromatography (UHPLC, Thermofisher Scientific, Waltham, MA, USA) using a UHPLC-DAD system. It consisted of a Thermo Scientific™ Dionex™ UltiMate™ 3000 BioRS equipped with a WPS-3000TBRS autosampler and a TCC-3000RS column compartment set at 35 °C. The system was operated using Chromeleon 7 software (Thermofisher Scientific, Waltham, MA, USA). An Accucore C18 column (2.6 µm, 100 × 2.1 mm2) combined with a security guard ultra-cartridge (Phenomenex Inc., Torrance, CA, USA) was used. An isocratic binary solvent system was utilized, consisting of water/formic acid (1%, v/v) as solvent A and acetonitrile/formic acid (1%, v/v) as solvent B (90%A, 10%B). The flow rate of the mobile phase was 1.5 mL/minute, and the injection volume was 50 μL. Quantitative analysis of paracetamol in the SODFs was carried out using an external standard method. The calibration curve was constructed using 5 different standard levels in the concentration range 1–20 mg/L. The peak of paracetamol was monitored at 244 nm.
+ Open protocol
+ Expand
3

Fractionation and Desalting of iTRAQ-Labeled Peptides

Check if the same lab product or an alternative is used in the 5 most similar protocols
The iTRAQ labeled peptides were mixed in equal amounts and fractioned by an HPLC system (Thermo Scientific Dionex UltiMate 3000 BioRS, Thermo Scientific, Shanghai, China) using the Durashell C18 column (5 μm, 100 Å, 4.6 mm × 250 mm). The dried peptides were dissolved in 100 μL buffer A (20 mM NH4HCO3 in 3% acetonitrile, pH 10), and were then loaded onto the HPLC device at a flow rate of 1 mL/min with buffer B (20 mM NH4HCO3, pH 10) at gradients of 0–8% for 5 min; 8–45% for 25 min; 45–80% for 15 min; and 80–100% for 5 min. The eluted fractions were collected at 1-min intervals and pooled into 12 fractions, then desalted with a Strata X C18 column (Phenomenex, Guangzhou, China) and vacuum-dried.
+ Open protocol
+ Expand
4

Quantification of Ibuprofen Formulations by UHPLC

Check if the same lab product or an alternative is used in the 5 most similar protocols
For each formulation, three SOFs were dissolved in 100 mL of a mixture (40%/60%) of solvent A (distilled water/formic acid (1%, v/v)) and solvent B (acetonitrile). Samples of the solutions were then diluted and the concentration of the drug was determined by ultra-high performance liquid chromatography (UHPLC) using a UHPLC-DAD system. This consisted of a Thermo Scientific™ Dionex™ UltiMate™ 3000 BioRS equipped with a WPS-3000TBRS autosampler and a TCC-3000RS column compartment set at 35 °C (Thermofisher Scientific, Waltham MA, USA). The system was operated using Chromeleon 7 software. An Accucore C18 column (2.6 µm, 100 mm × 2.1 mm) combined with a security guard ultra-cartridge (Phenomenex Inc., Torrance CA, USA) was used. An isocratic binary solvent system was utilized, consisting of solvent A and solvent B (40%A, 60%B). The flow rate of the mobile phase was 1.5 mL/minute, and the injection volume was 50 μL. Quantitative analysis of IbuAc and IbuNa in the SOFs was carried out using an external standard method. The calibration curve for each form of the drug was constructed using 5 different standard levels of the corresponding form in the concentration range 1–20 mg/L. The peak of ibuprofen was monitored at 258 nm.
+ Open protocol
+ Expand
5

Isobaric Peptide Labeling and Fractionation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Samples were labeled with iTRAQ 8-plex Multiplex Reagent Kit (AB Sciex U.K.) by following the manufacturer's instructions. All labeled samples were mixed in equal volume and fractionated using a high-performance liquid chromatography (HPLC) system (Thermo Dionex Ultimate 3000 BioRS).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!